Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Explanation for the Adiponectin Paradox. | Pharmaceuticals (Basel) | 2021 | 34959666 | PubTator, text mining | PubMed |
| Plasma Proteomics Characteristics of Subclinical Vitamin E Deficiency of Dairy Cows During Early Lactation. | Front Vet Sci | 2021 | 34957273 | PubTator, text mining | PubMed |
| Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications. | Front Endocrinol (Lausanne) | 2021 | 34956100 | PubTator, text mining | PubMed |
Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue "Diagnosis and Management of Endometrial Cancer". | Cancers (Basel) | 2021 | 34944775 | PubTator, text mining | PubMed |
| Lipid Droplets, Phospholipase A2, Arachidonic Acid, and Atherosclerosis. | Biomedicines | 2021 | 34944707 | PubTator, text mining | PubMed |
| RalA, PLD and mTORC1 Are Required for Kinase-Independent Pathways in DGKβ-Induced Neurite Outgrowth. | Biomolecules | 2021 | 34944458 | PubTator, text mining | PubMed |
| Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial. | Curr Oncol | 2021 | 34940072 | PubTator, text mining | PubMed |
| Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources. | Front Pharmacol | 2021 | 34925017 | PubTator, text mining | PubMed |
| Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma. | Int J Gen Med | 2021 | 34908869 | PubTator, text mining | PubMed |
| Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation. | Nat Commun | 2021 | 34907161 | PubTator, text mining | PubMed |
| Endocytic proteins with prion-like domains form viscoelastic condensates that enable membrane remodeling. | Proc Natl Acad Sci U S A | 2021 | 34887356 | PubTator, text mining | PubMed |
| The Differential Reactive Oxygen Species Production of Tear Neutrophils in Response to Various Stimuli In Vitro. | Int J Mol Sci | 2021 | 34884704 | PubTator, text mining | PubMed |
| A secretory phospholipase D hydrolyzes phosphatidylcholine to suppress rice heading time. | PLoS Genet | 2021 | 34879072 | PubTator, text mining | PubMed |
| Alleviation of Postharvest Chilling Injury of Carambola Fruit by γ-aminobutyric Acid: Physiological, Biochemical, and Structural Characterization. | Front Nutr | 2021 | 34869526 | PubTator, text mining | PubMed |
| Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders. | Life (Basel) | 2021 | 34833002 | PubTator, text mining | PubMed |
| Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. | Pathogens | 2021 | 34832669 | PubTator, text mining | PubMed |
| Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment. | Cells | 2021 | 34831439 | PubTator, text mining | PubMed |
| Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System. | Cells | 2021 | 34831185 | PubTator, text mining | PubMed |
| Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. | Cells | 2021 | 34831180 | PubTator, text mining | PubMed |
| Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy. | Cells | 2021 | 34831054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=41